Survival Improving in Metastatic Bladder Cancer Cases
Trend may reflect increasing use of systemic immunotherapies as first-line treatments, according to investigators.
Diagnosis & Disease Information
Study Could Guide Therapeutic Choices for mCSPC
A recent systematic review and meta-analysis provides the most up-to-date evidence for performance of triplet therapy compared with API-based doublets in mCSPC.
R-MIV Is an Effective Induction Regimen for Patients With Primary Central Nervous System Lymphoma
Researchers sought to determine whether induction with R-MIV would be an effective treatment for primary CNS lymphoma.
Neoadjuvant Chemotherapy-Induced AKI Tied With Worse MIBC Outcomes
Acute kidney injury frequently occurs during neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Progression-free, overall survival significantly lower for female patients receiving chemo mostly in morning.
Virtual Reality Intervention Reduces Pediatric Patient Anxiety at First Chemotherapy
An exploratory study sought to determine the effects of using an immersive virtual reality intervention on pediatric patients during early chemotherapy sessions.
Posttreatment Benefits of ONNs on Hospital Admissions, ED Visits Limited
Investigators sought to determine the effect of oncology nurse navigator involvement on posttreatment ED visits and hospitalizations for patients with cancer treated with chemotherapy.
Pedmark Now Available to Reduce Risk of Cisplatin-Induced Hearing Loss in Children
Pedmark is the first FDA-approved therapy indicated to reduce the risk of cisplatin-induced hearing loss in children.
Regimen Offers Hope for Children with Type II and III Pleuropulmonary Blastoma
Researchers evaluated the efficacy of a regimen of ifosfamide, vincristine, actinomycin-D, and doxorubicin (IVADo) in children with type II and type III pleuropulmonary blastoma.
Treatment Sequencing Improves Cost-Effectiveness, Value of Care in Metastatic Breast Cancer
Researchers sought to determine how sequence of first- to third-line treatment of metastatic breast cancer influences cost and value of care.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...